谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.

Glenwood D Goss,Everett E Vokes,Michael S Gordon,Leena Gandhi,Kyriakos P Papadopoulos,Drew W Rasco,JuDee S Fischer,Katharine L Chu,William W Ames,Rajendar K Mittapalli,Ho-Jin Lee,Jiewei Zeng,Lisa A Roberts-Rapp,Lise I Loberg,Peter J Ansell,Edward B Reilly,Christopher J Ocampo,Kyle D Holen,Anthony W Tolcher

CANCER（2018）

引用 51|浏览44
暂无评分
关键词
ABT-414,antibody-drug conjugate,epidermal growth factor receptor (EGFR),depatuxizumab mafodotin (depatux-m)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要